Veteran Actor, Sadiq Daba Reportedly Suffering from Prostate Cancer
The actor who has had bouts of ailments has again been diagnosed of prostate cancer.
In a phone conversation with Sunday Scoop, veteran actor, Sadiq Daba, said that he is left to choose between having his prostates out, which translates to him being castrated or taking an injection which will cost him a Hundred and Fifty Thousand Naira every two months.
Speaking on the kind of support he has gotten so far from colleagues, he mentioned the names of few people in the industry that has supported him so far, adding that he does not want want to be castrated.
Extracts below…
“Right now, I have a catheter inserted into my penis to ease the movement of urine. I have been in and out of hospitals for a while now. Next week, I also have to go for a biopsy to determine if I would need to do a major surgery. I have leukemia to battle with, then this prostate issue comes in. The pain is just too much for me.
I have been receiving treatment at LASUTH and OAUTH and the doctors have been wonderful. I was told that one of the side effects of the surgery is that my testicles would have to be removed. That means I would be castrated and I don’t think I want that. The other option is that I would have to take injections that would cost N150,000 every two months, and I have to take it for about two years. You can imagine what the total cost would be.
A few of my colleagues have been wonderful; they have tried to help as much as they can. The DGs of NTA, Censors Board, and the president of PMAN have also been of help. I can’t start carrying bowls and be going all about the place begging for money. I believe I have paid my dues. For those who know about my situation and want to help, they are welcome. Everything that I have to do is tied to money. There is no drug that is cheap.”
We would recall that the actor the actor who was receiving treatment for leukemia was rumoured dead in September but debunked such rumours as he was said to be responding to treatment. Read here.